From Pacific Research Institute <[email protected]>
Subject Read how free-market advocates are getting it wrong on PBM reform
Date February 13, 2024 5:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
View this email in your browser ([link removed])
[link removed]
Reforming PBMs Improves the Drug Market and Thwarts Efforts to Socialize Medicine
Townhall | February 9, 2024 | Sally Pipes & Wayne Winegarden

There they go again. Free-market advocates are jeopardizing pro-market healthcare reforms based on an inability to recognize how cronyism tars the current industry dynamics. That distinction between companies operating in a free market and companies using cronyism to flourish in a government-dominated market is the key.

Read here . . . ([link removed])
Is the FDA opening a door for counterfeit drug trade?
Dallas Morning News | Sally Pipes | February 8, 2024

The U.S. Food and Drug Administration gave the go-ahead last month for Florida to import prescription drugs in bulk from Canada. If all goes according to plan, the state government will be able to dispense certain Canadian-sourced drugs to people who receive care through the state Department of Corrections, the state Department of Children and Families, and the state Agency for Persons with Disabilities.

Read more... ([link removed])

------------------------------------------------------------
Can Constitution Save Us From Drug Price Controls?
Newsmax | Sally Pipes | February 9, 2024

AstraZeneca made its case ([link removed]) against Medicare’s prescription drug price-setting scheme before a federal judge in Delaware last week. It’s one of several drugmakers challenging the program ([link removed]) on constitutional grounds, among them Johnson & Johnson, Merck and Bristol Myers Squibb.

Read more... ([link removed])

[link removed]

============================================================
** Twitter ([link removed])
** Facebook ([link removed])
** YouTube ([link removed])
** LinkedIn ([link removed])
** Instagram ([link removed])
** Website ([link removed])
Copyright © 2024 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
P.O. Box 60485 Pasadena, CA 91116

** ([link removed])

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis